GliaPharm is a Swiss biotechnology company that develops treatments for neurological and psychiatric disorders.
GliaPharm est une entreprise suisse de biotechnologies active dans le développement de traitements de maladies neurologiques et psychiatriques.
GliaPharm has been selected as Hello Tomorrow's Top 500 Deeptech Startups worldwide. Hello Tomorrow Global Summit will take place in Paris, 14-15th March 2019.
GliaPharm receives the Cydan Award of the MassChallenge startup Accelerator program in Boston, 2017
GliaPharm has been selected as a Finalist to the MassChallenge Switzerland 2017 startup contest